Related Experiment Video
Updated: Jun 16, 2025
07:18
Author Spotlight: A Unique Mouse Model of Asphyxia-Induced Cardiac Arrest
Published on: April 14, 2023
1.7K
Serial Systemic Immune-Inflammation Indices (SSIIi) as Prognostic Markers in Persistent Hypoxic Brain Injury
Tissa Wijeratne1,2, Sheila G Crewther3, Chanith Wijeratne4
1Department of Neurology, Western Health, La Trobe University, St. Albans, AUS.
Cureus
|August 21, 2024
Summary
Serial systemic immune-inflammation indices (SSIIi) may predict poor outcomes in critical care. Persistently elevated SSIIi in the initial 24-72 hours suggests a maladaptive immune response and poor prognosis.
Area of Science:
- Critical Care Medicine
- Immunology
- Biomarker Discovery
Background:
- Prognostic biomarkers are crucial in critical care for guiding patient management.
- Systemic immune-inflammation indices (SSIIi) offer a potential window into patient response.
- Evaluating novel biomarkers like SSIIi is essential for improving outcomes.
Observation:
- A case report details a 31-year-old male following a heroin overdose and cardiac arrest.
- Serial systemic immune-inflammation indices (SSIIi) were monitored during intensive care unit (ICU) stay.
- The patient's SSIIi showed rapid escalation and sustained high values.
Findings:
- Persistently elevated SSIIi within 24-72 hours may indicate a maladaptive immune response.
- High SSIIi correlated with ongoing inflammation and a deteriorating clinical trajectory.
- The observed SSIIi pattern predicted a poor prognosis in this critical care case.
Implications:
- SSIIi could serve as a valuable prognostic tool in ICU settings, especially for hypoxic brain injury without sepsis.
- Objective measures like SSIIi may aid clinicians in treatment decisions.
- Further research into SSIIi could enhance patient outcome prediction and management strategies.
